Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
Reliant Glycosciences is a biotechnology company focused on developing diagnostic and prognostic tools for patients with IgA nephropathy.
Pioneering innovative biomedical technologies
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Tabula Rasa enables medication optimization using its medication risk mitigation technology.
ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.
PediaMetrix brings AI and computer vision to pediatric health to lower cost and improve outcome.
Cell Microsystems develops, manufactures, and markets innovative products for single-cell biology.
Cerecor discovers, develops and commercializes neuroscience drugs.
Reduce clinical variation and gain 10x efficiencies – continuous insights and monitoring
XLerateHealth is enterprise-focused and will help early stage healthcare companies build out their commercialisation strategy.
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
Penderia Technologies is a new medical device company that specializes in creative ways to treat orthopedic ailments.
Linshom is first to deliver an AI enabled, wearable, FDA cleared, operating room quality respiratory profile to the patient bedside.
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities.
Inso Bio is developing automtion tools for genomic sample handling.
Developing blood-based diagnostic tests for the early detection of neurological disorders like Alzheimer's disease.
Autonomous Healthcare is a medical technology company pioneering the use of automation in clinical care workflows
Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
Melax Technologies specializes in machine learning, software, domain, natural language processing and medical coding services.
Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.
Sur180 Therapeutics is a female-led business that focuses on novel ways to treating gynecological diseases.
We build applications that use speech to detect subtle changes in brain health.
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical Device, Medical, Life Science. The firm invests across 24 different industry categories.
Among tracked funding rounds, Cerecor received $10.0M in a Post-IPO Debt round. National Institutes of Health's total known invested capital is $1.9B.
National Institutes of Health's average investment size is $4.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Evoq Therapeutics, Reliant Glycosciences, Great Lakes NeuroTechnologies Inc., Astrocyte Pharmaceuticals, Tabula Rasa Healthcare (formerly CareKinesis). These companies were founded in 2020 or later.